| |
|
|
|
| Unsafe Drugs
:: Heparin
|
HEPARIN - In February 2008, Baxter International, the primary manufacturer of Heparin in the United States, recalled all of its Heparin products after pressure from the FDA. The FDA believed that at the time at least 400 life threatening reactions and as many as 25 deaths were caused by Baxter's Heparin products.
Heparin is a very popular blood thinner used in surgery and dialysis and thus a big money maker for Baxter. Baxter was aware of the manufacturing defects that caused their Heparin products to cause serious and often fatal reactions, but they were slow to react essentially standing by as more and more people were hurt by their defective drug.
They not only left the drug in circulation longer than it should have been once they were aware of the defects, but they never once inspected their foreign manufacturer's facility to ensure that the drug was being made to specification. It turns out that their foreign manufacturer was not following the necessary procedures nor taking the necessary safety precautions in order to make sure that contaminents don't infuse the drug. Baxter's failure to regulate their foreign manufacturer caused tens of thousands of people to come in contact with a dangerous and defective drug.
Patients that have been given the contaminated Heparin have reported experiencing generalized or localized sensations of warmth, numbness or tingling of the extremities, difficulty swallowing, shortness of breath, audible wheezing, chest tightness, low blood pressure, nausea and vomiting, abdominal pain, diarrhea, dizziness, drug ineffectiveness, dyspepsia, dyspnea, erythema, flushing, headache, hyperhidrosis, hypoesthesia, hypotension, loss of consciousness, malaise, pallor, palpitations, paresthesia, pharyngeal edema, restlessness, tachycardia, and unresponsiveness to stimuli.
The negligence exhibited by Baxter has led thousands of innocent people to experience these serious and often fatal reactions. We intend to hold them accountable for their reckless behavior.
Unsafe drug cases are complex and costly to litigate. Experienced representation is essential, and that is exactly what we help provide. If you believe you or a loved one suffered a serious complication as a result of being administered Heparin, please fill out the form below for a free evaluation.
Keywords: Heparin Lawsuit | Heparin Lawyers | Heparin Attorneys | Heparin Lawyer | Heparin Attorney
|
| Free Case Evaluation |
Use the form below to submit your case and receive a free evaluation. By submitting this form, you certify that you agree to our Terms and Conditions and want us to contact you regarding your inquiry. Required fields are marked in BOLD.
|
| Heparin In the News |
Companies Race to Develop Drugs to Reduce Blood-Clotting Problems - New York Times
Companies Race to Develop Drugs to Reduce Blood-Clotting ProblemsNew York TimesAn FDA approval for the new drug, analysts said, would help offset the company's expected losses from Plavix, a best-selling anticlotting drug...
More Information »
Judge Refuses to Block Generic Lovenox - Wall Street Journal
Judge Refuses to Block Generic LovenoxWall Street Journal... July after the FDA gave Sandoz approval to make the generic form of the special heparin, called enoxaparin, which is used in cardiovascular ailments. ...JUDGE...
More Information »
FDA's Safety Role in Question After Egg Recall - NewsHour
FDA's Safety Role in Question After Egg RecallNewsHourBETTY ANN BOWSER: In 2008, 81 people died in the US after being given the blood thinner heparin. Ingredients for its manufacture came from China. ...and...
More Information »
Amid Chinese Food Scares FDA Has Limited Scope - Wall Street Journal (blog)
Amid Chinese Food Scares FDA Has Limited ScopeWall Street Journal (blog)Some congressmen have been critical of China's response two years ago to a scare in the US over contamination of the widely used blood thinner...
More Information »
FDA Approves Generic Enoxaparin - Journal of American Medical Association (subscription)
FDA Approves Generic EnoxaparinJournal of American Medical Association (subscription)FDA approval of generic enoxaparin was particularly challenging. The drug, which is made from heparin that is derived from pig intestines,...
More Information »
Rivaroxaban almost superior to usual care in treatment of DVT - TheHeart.Org
Rivaroxaban almost superior to usual care in treatment of DVTTheHeart.OrgBut although usual care is effective, it is inconvenient, requiring initial subcutaneous injections of low-molecular-weight heparin (LMWH) followed by...
More Information »
SNY Seeks to Expand Vaccine Label - Zacks.com
SNY Seeks to Expand Vaccine LabelZacks.comLovenox, an anti-coagulant/blood thinner analog of heparin, is a major contributor to the top line with 2009 sales coming in at €3043 million, up 11.1%. ...and more »
More Information »
The Dickensian Character from US Business: A Biosecurity Threat - Global Security
The Dickensian Character from US Business: A Biosecurity ThreatGlobal SecurityA year ago [in 2007] Baxter International and another US company it did business with killed people by selling tainted heparin. Heparin is a...
More Information »
Best of MedCitizens: NYT failings, FDA upgrades - MedCity News
MedCity NewsBest of MedCitizens: NYT failings, FDA upgradesMedCity NewsSome Democrats seek bigger FDA budget in 2012. “Citing a myriad of recent FDA headlines, such as a heparin contamination episode in 2009 and a series of...
More Information »
Hamburg offers balanced sound bites from China trip - FiercePharma Manufacturing
Hamburg offers balanced sound bites from China tripFiercePharma ManufacturingLawmakers have been aggressive in questioning her about Chinese imports, in particular the contaminated heparin of several years ago but also the...
More Information »
China a good place to start fight against fake APIs - FiercePharma Manufacturing
China a good place to start fight against fake APIsFiercePharma ManufacturingRecent cases of hazardous material showing up in drugs include the contaminated heparin case of 2007/2008, which led to hundreds of serious...
More Information »
Trading FDA, Clinical Trial Binary Events: $DEPO $EXAS $JAZZ $PYMX.OB - FavStocks (blog)
Trading FDA, Clinical Trial Binary Events: $DEPO $EXAS $JAZZ $PYMX.OBFavStocks (blog)The earnings report was much better than anticipated, and may provide a nice boost heading into the FDA Panel. JAZZ briefly crossed the $10...
More Information »
Ash Access Technology, Inc. Has Been Granted a Key United States Patent for ... - Marketwire (press release)
Ash Access Technology, Inc. Has Been Granted a Key United States Patent for ...Marketwire (press release)... attractive safety profile compared to the current standard of care -- high concentration Heparin. AAT is seeking FDA...
More Information »
What's going to be hot at ESC 2010 Congress - TheHeart.Org
What's going to be hot at ESC 2010 CongressTheHeart.OrgAlso on offer are sessions on new ESC guidelines, a joint FDA/EMEA session on regulatory issues and clinical research, and a series of best-abstract ...and...
More Information »
Tips and pearls: Minimizing blood transfusion following primary total knee ... - Ortho SuperSite
Tips and pearls: Minimizing blood transfusion following primary total knee ...Ortho SuperSiteA prospective, randomized trial comparing a mobile compression device with low-molecular-weight heparin. J Bone Joint Surg (Am) ....
More Information »
Amphastar fights seal in Baxter heparin suit - FiercePharma
Amphastar fights seal in Baxter heparin suitFiercePharmaPlus, Amphastar claims, the depositions could be important to a congressional investigation into the FDA's role in the heparin crisis. ...and more »
More Information »
Lucky Picks of The Day: (OTCBB:MWIS)- (OTCBB:PYMX)- (OTCBB:SECI) - TMC Net
Lucky Picks of The Day: (OTCBB:MWIS)- (OTCBB:PYMX)- (OTCBB:SECI)TMC NetPMX-60056, PolyMedix's lead heptagonist compound, is being developed to reverse the anticoagulant activity of both heparin and low molecular weight...
More Information »
First Patient Receives Vascular Access Graft in Study - Renal Business Today
First Patient Receives Vascular Access Graft in StudyRenal Business Today... is the only prosthetic vascular graft to combine predictable self-sealing with improved handling and a surface bonded with heparin, according to...
More Information »
FDA: TQ có tiến bộ trong việc giám sát thực phẩm và dược phẩm - VOA Tiếng Việt
FDA: TQ có tiến bộ trong việc giám sát thực phẩm và dược phẩmVOA Tiếng ViệtGiám đốc cơ quan Quản lý Thực phẩm và Dược phẩm của Hoa Kỳ, FDA, nói rằng Trung Quốc đã làm tốt hơn trong việc giám sát các loại thức ăn xuất khẩu....
More Information »
|
|
| |